GMP - GMP Unit at SCI-TReCS
Director: Univ.-Prof. Dr. Eva Rohde
The GMP (= Good Manufacturing Practice) Unit of the Center for Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS) develops and manufactures new cell-based therapeutic products (ATMPs and biologicals). These include, among others, extracellular vesicles (EV) and exosomes of multipotent stromal cells (MSC). [see homepage]
Research
Upstream Technology
- establishment of scalable technologies for the production of EVs (bioreactor technologies) under GMP conditions
- validation of immortalized cell lines as a stable starting resource for quality assurance of production
- manufacture of master and working cell banks to ensure consistent output cells
Downstream Technology
- establishment and validation of a GMP compliant production train via tangential flow filtration (TFF) and size exclusion chromatography (SEC)
- development of nanoparticle tracking analysis (NTA / FL-NTA) analysis systems for quality control and product release
- establishment and validation of analytical methods for the determination of biological and therapeutic potency
Transfer
- manufacture of master cell banks and working cell banks from primary and immortalized cells
- studies to optimize the inoculum for the use of bioreactors
- GMP compliant equipment qualification and process validation
- manufacturing and quality control of MSC-EV
- purification and characterization of EVs from human platelet lysate (HPL)